Landfill search begins for remains of Ashlee Shingoose in Winnipeg | Unpublished
Hello!
Source Feed: The Globe and Mail
Author: Temur Durrani
Publication Date: December 1, 2025 - 16:12

Stay informed

Landfill search begins for remains of Ashlee Shingoose in Winnipeg

December 1, 2025

Manitoba has begun a search at a Winnipeg landfill to recover the remains of Ashlee Shingoose, one of four First Nations women murdered by a serial killer and the only victim authorities had been unable to identify until earlier this year.

For years, Ms. Shingoose, of St. Theresa Point First Nation, was referred to as Mashkode Bizhiki’ikwe, meaning Buffalo Woman. It was a spirit name in Anishinaabemowin that Indigenous elders had given to her in 2022, when she was killed at the age of 30 by Jeremy Skibicki.



Unpublished Newswire

 
Alberta Premier Danielle Smith pointed to her advisers when asked to explain how an Edmonton businessman whose contracts with the province’s health agency are now under scrutiny ended up in a hotel suite with her top lieutenants on the night of the 2023 provincial election. A Globe and Mail investigation published over the weekend examined the links between medical supply company executive Sam Mraiche and Ms. Smith’s government. The Globe found Mr. Mraiche, whose company MHCare was awarded more than $600-million in contracts with Alberta Health Services, had more extensive connections to...
December 1, 2025 - 22:01 | Matthew Scace, Emma Graney | The Globe and Mail
For now, Cole says he walks the perimeter of his home every night, checking for any unwanted visitors and hoping nothing like this happens again.
December 1, 2025 - 21:55 | Victoria Femia | Global News - Canada
More cases of prostate cancer were diagnosed at Stage 4 in recent years compared with about a decade earlier, a development that experts behind a new study suggest could be linked with official recommendations discouraging the use of a hotly debated screening test.The prostate-specific antigen test is a simple blood test that can serve as an early warning signal of cancer in men with no symptoms. But the test also has risks: It can lead to overdiagnosis and overtreatment of slow-growing prostate tumours that might never have caused harm had they remained undiscovered. For that reason, a...
December 1, 2025 - 20:45 | Kelly Grant | The Globe and Mail